カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

再構成組織の世界市場2022：動物細胞組織、ヒト組織、その他

◆英語タイトル：Global Reconstructed Tissue Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO18399 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：105 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

再構成組織市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の再構成組織の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

再構成組織市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・動物細胞組織、ヒト組織、その他

用途別セグメントは次のように区分されます。
・病院、創傷ケアセンター、その他

世界の再構成組織市場の主要な市場プレーヤーは以下のとおりです。
・Integra Life Sciences、Smith & Nephew、Organogenesis、MiMedx、Tissue Regenix、Mylan、Allergan、PermeaDerm、Yantai Zhenghai Bio-tech、Guanhao Biotech

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、再構成組織製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な再構成組織メーカーの企業概要、2019年～2022年までの再構成組織の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な再構成組織メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別再構成組織の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの再構成組織の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での再構成組織市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および再構成組織の産業チェーンを掲載しています。
・第13、14、15章では、再構成組織の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 再構成組織の概要
- 種類別分析（2017年vs2021年vs2028年）：動物細胞組織、ヒト組織、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、創傷ケアセンター、その他
- 世界の再構成組織市場規模・予測
- 世界の再構成組織生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Integra Life Sciences、Smith & Nephew、Organogenesis、MiMedx、Tissue Regenix、Mylan、Allergan、PermeaDerm、Yantai Zhenghai Bio-tech、Guanhao Biotech
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：動物細胞組織、ヒト組織、その他
・用途別分析2017年-2028年：病院、創傷ケアセンター、その他
・再構成組織の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・再構成組織のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・再構成組織のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・再構成組織の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・再構成組織の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Reconstructed Tissue market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Reconstructed Tissue market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Reconstructed Tissue global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Animal Cell Tissue segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Reconstructed Tissue include Integra Life Sciences, Smith & Nephew, Organogenesis, MiMedx, and Tissue Regenix, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Reconstructed Tissue market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Animal Cell Tissue
Human Tissue
Others
Market segment by Application can be divided into
Hospitals
Wound Care Centers
Others
The key market players for global Reconstructed Tissue market are listed below:
Integra Life Sciences
Smith & Nephew
Organogenesis
MiMedx
Tissue Regenix
Mylan
Allergan
PermeaDerm
Yantai Zhenghai Bio-tech
Guanhao Biotech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Reconstructed Tissue product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Reconstructed Tissue, with price, sales, revenue and global market share of Reconstructed Tissue from 2019 to 2022.
Chapter 3, the Reconstructed Tissue competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Reconstructed Tissue breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Reconstructed Tissue market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Reconstructed Tissue.
Chapter 13, 14, and 15, to describe Reconstructed Tissue sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Reconstructed Tissue Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Reconstructed Tissue Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Animal Cell Tissue
1.2.3 Human Tissue
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Reconstructed Tissue Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Wound Care Centers
1.3.4 Others
1.4 Global Reconstructed Tissue Market Size & Forecast
1.4.1 Global Reconstructed Tissue Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Reconstructed Tissue Sales in Volume (2017-2028)
1.4.3 Global Reconstructed Tissue Price (2017-2028)
1.5 Global Reconstructed Tissue Production Capacity Analysis
1.5.1 Global Reconstructed Tissue Total Production Capacity (2017-2028)
1.5.2 Global Reconstructed Tissue Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Reconstructed Tissue Market Drivers
1.6.2 Reconstructed Tissue Market Restraints
1.6.3 Reconstructed Tissue Trends Analysis
2 Manufacturers Profiles
2.1 Integra Life Sciences
2.1.1 Integra Life Sciences Details
2.1.2 Integra Life Sciences Major Business
2.1.3 Integra Life Sciences Reconstructed Tissue Product and Services
2.1.4 Integra Life Sciences Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Smith & Nephew
2.2.1 Smith & Nephew Details
2.2.2 Smith & Nephew Major Business
2.2.3 Smith & Nephew Reconstructed Tissue Product and Services
2.2.4 Smith & Nephew Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Organogenesis
2.3.1 Organogenesis Details
2.3.2 Organogenesis Major Business
2.3.3 Organogenesis Reconstructed Tissue Product and Services
2.3.4 Organogenesis Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 MiMedx
2.4.1 MiMedx Details
2.4.2 MiMedx Major Business
2.4.3 MiMedx Reconstructed Tissue Product and Services
2.4.4 MiMedx Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Tissue Regenix
2.5.1 Tissue Regenix Details
2.5.2 Tissue Regenix Major Business
2.5.3 Tissue Regenix Reconstructed Tissue Product and Services
2.5.4 Tissue Regenix Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Reconstructed Tissue Product and Services
2.6.4 Mylan Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business
2.7.3 Allergan Reconstructed Tissue Product and Services
2.7.4 Allergan Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 PermeaDerm
2.8.1 PermeaDerm Details
2.8.2 PermeaDerm Major Business
2.8.3 PermeaDerm Reconstructed Tissue Product and Services
2.8.4 PermeaDerm Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Yantai Zhenghai Bio-tech
2.9.1 Yantai Zhenghai Bio-tech Details
2.9.2 Yantai Zhenghai Bio-tech Major Business
2.9.3 Yantai Zhenghai Bio-tech Reconstructed Tissue Product and Services
2.9.4 Yantai Zhenghai Bio-tech Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Guanhao Biotech
2.10.1 Guanhao Biotech Details
2.10.2 Guanhao Biotech Major Business
2.10.3 Guanhao Biotech Reconstructed Tissue Product and Services
2.10.4 Guanhao Biotech Reconstructed Tissue Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Reconstructed Tissue Breakdown Data by Manufacturer
3.1 Global Reconstructed Tissue Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Reconstructed Tissue Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Reconstructed Tissue
3.4 Market Concentration Rate
3.4.1 Top 3 Reconstructed Tissue Manufacturer Market Share in 2021
3.4.2 Top 6 Reconstructed Tissue Manufacturer Market Share in 2021
3.5 Global Reconstructed Tissue Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Reconstructed Tissue Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Reconstructed Tissue Market Size by Region
4.1.1 Global Reconstructed Tissue Sales in Volume by Region (2017-2028)
4.1.2 Global Reconstructed Tissue Revenue by Region (2017-2028)
4.2 North America Reconstructed Tissue Revenue (2017-2028)
4.3 Europe Reconstructed Tissue Revenue (2017-2028)
4.4 Asia-Pacific Reconstructed Tissue Revenue (2017-2028)
4.5 South America Reconstructed Tissue Revenue (2017-2028)
4.6 Middle East and Africa Reconstructed Tissue Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Reconstructed Tissue Sales in Volume by Type (2017-2028)
5.2 Global Reconstructed Tissue Revenue by Type (2017-2028)
5.3 Global Reconstructed Tissue Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Reconstructed Tissue Sales in Volume by Application (2017-2028)
6.2 Global Reconstructed Tissue Revenue by Application (2017-2028)
6.3 Global Reconstructed Tissue Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Reconstructed Tissue Sales by Type (2017-2028)
7.2 North America Reconstructed Tissue Sales by Application (2017-2028)
7.3 North America Reconstructed Tissue Market Size by Country
7.3.1 North America Reconstructed Tissue Sales in Volume by Country (2017-2028)
7.3.2 North America Reconstructed Tissue Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Reconstructed Tissue Sales by Type (2017-2028)
8.2 Europe Reconstructed Tissue Sales by Application (2017-2028)
8.3 Europe Reconstructed Tissue Market Size by Country
8.3.1 Europe Reconstructed Tissue Sales in Volume by Country (2017-2028)
8.3.2 Europe Reconstructed Tissue Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Reconstructed Tissue Sales by Type (2017-2028)
9.2 Asia-Pacific Reconstructed Tissue Sales by Application (2017-2028)
9.3 Asia-Pacific Reconstructed Tissue Market Size by Region
9.3.1 Asia-Pacific Reconstructed Tissue Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Reconstructed Tissue Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Reconstructed Tissue Sales by Type (2017-2028)
10.2 South America Reconstructed Tissue Sales by Application (2017-2028)
10.3 South America Reconstructed Tissue Market Size by Country
10.3.1 South America Reconstructed Tissue Sales in Volume by Country (2017-2028)
10.3.2 South America Reconstructed Tissue Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Reconstructed Tissue Sales by Type (2017-2028)
11.2 Middle East & Africa Reconstructed Tissue Sales by Application (2017-2028)
11.3 Middle East & Africa Reconstructed Tissue Market Size by Country
11.3.1 Middle East & Africa Reconstructed Tissue Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Reconstructed Tissue Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Reconstructed Tissue and Key Manufacturers
12.2 Manufacturing Costs Percentage of Reconstructed Tissue
12.3 Reconstructed Tissue Production Process
12.4 Reconstructed Tissue Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Reconstructed Tissue Typical Distributors
13.3 Reconstructed Tissue Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 再構成組織の世界市場2022：動物細胞組織、ヒト組織、その他(Global Reconstructed Tissue Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

再構成組織の世界市場2022：動物細胞組織、ヒト組織、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp